24
Apr2018

At the recent PRIM&R IACUC18 Preconference Program, I was excited to see that there was a session dedicated to improving communication and reducing burden between the IACUC and Institutional Biosafety Committee (IBC). Like many of you, I wear multiple hats and serve as both the IACUC and IBC Administrator. I am always looking for ways to streamline processes and reduce burden while improving communication across compliance groups. Even if you only oversee the IACUC, animal research is beginning more and more frequently to involve biological agents that will require IBC review and oversight. Having a solid understanding of the IBC regulations and practices can help reduce burden on investigators and improve communication between compliance committees. Read more

23
Apr2018

Like many others, I attended the 2017 Advancing Ethical Research Conference eager to hear presentations from the experts, but also looking forward to hearing from other attendees about their interpretations of the revisions to the Common Rule. I went in with a list of questions a mile long. Read more

20
Apr2018

Columbus was a wonderful locale for PRIM&R’s 2018 IACUC Conference and certainly demonstrated what the first few days of spring can look like in the Midwest! The PRIM&R Board, Planning Committee, and staff consistently manage to organize an outstanding array of keynote speakers along with amazing breakout sessions and workshops. Read more

18
Apr2018

As a relative newcomer to the IRB administrator profession, one of my goals for the 2017 Advancing Ethical Resesarch Conference was to meet and develop a network of other professionals at institutions similar to my own. At my institution, I am the only full-time IRB administrator, and at times, it can feel like I am alone in the wilderness of IRB administration. While there are countless useful resources available online, there is often much more nuance and perspective to be gained by being able to bounce ideas and discuss pitfalls with a more experienced individuals Read more

17
Apr2018

This post draws on information I learned from two presentations. The first, “SBER in the Era of the Revised Common Rule: An Overview of the Most Relevant Regulatory Changes” by Yvonne Lau, MBBS, MBHL, PhD (Director, Division of Education and Development, Office for Human Research Protections), was given at PRIM&R’s 2017 AER conference. The second, “Clinical Trials in the SBER Context” by Melissa W. Riddle, PhD (Chief, Behavioral and Social Sciences Research Branch, National Institute of Dental and Craniofacial Research) and Cindy S. Shindledecker, CIP (Director, Health Sciences and Behavioral Sciences Institutional Review Board, University of Michigan), was given at PRIM&R’s 2017 SBER conference. (Dr. Riddle was absent, but her colleague Wendy Webber, ND, PhD, MPH (Acting Deputy Director, National Center for Complementary and Integrative Health) was able to do an impromptu presentation on behalf of NIH.) Read more

Page 1 of 18812345...102030...Last »